- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/51 - Umbilical cordUmbilical cord bloodUmbilical stem cells
Patent holdings for IPC class A61K 35/51
Total number of patents in this class: 713
10-year publication summary
|
63
|
75
|
77
|
70
|
69
|
67
|
61
|
58
|
42
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biotissue Holdings Inc. | 84 |
19 |
| Rohto Pharmaceutical Co., Ltd. | 403 |
14 |
| Biostem Technologies, Inc. | 60 |
14 |
| CellResearch Corporation Pte Ltd. | 55 |
14 |
| Samsung Life Public Welfare Foundation | 707 |
13 |
| RegenLab USA LLC | 77 |
11 |
| Medipost Co., Ltd. | 48 |
10 |
| Minovia Therapeutics Ltd. | 51 |
10 |
| Osiris Therapeutics, Inc. | 103 |
10 |
| Board of Regents, The University of Texas System | 6004 |
8 |
| Duke University | 3157 |
8 |
| Gamida Cell Ltd. | 44 |
7 |
| Janssen Biotech, Inc. | 1626 |
7 |
| MiMedx Group, Inc. | 210 |
7 |
| Rutgers, The State University of New Jersey | 1956 |
7 |
| Therapeutic Solutions International, Inc. | 52 |
7 |
| University of South Florida | 1860 |
6 |
| FATE Therapeutics, Inc. | 219 |
6 |
| Fred Hutchinson Cancer Research Center | 352 |
6 |
| Jadi Cell LLC | 11 |
6 |
| Other owners | 523 |